Early visual symptom patterns in inherited retinal dystrophies

Ophthalmologica

Volumn 226, Issue 3, 2011, Pages 151-156

  Prokofyeva, Elena ^a   Troeger, Eric ^a   Wilke, Robert ^a,b   Zrenner, Eberhart ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Age at onset; Best corrected visual acuity; Inherited retinal dystrophies; Visual field defects; Visual symptoms

Indexed keywords

ARTICLE; HUMAN; NIGHT VISION; ONSET AGE; PHOTOPHOBIA; RETINA CONE; RETINA DYSTROPHY; RETINA ROD; RETINITIS PIGMENTOSA; VISION; VISUAL ACUITY; VISUAL FIELD DEFECT;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; RETINITIS PIGMENTOSA; RETROSPECTIVE STUDIES; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS; YOUNG ADULT;

EID: 81155161867     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000330381     Document Type: Article

References (34)

1. Bok D: Contributions of genetics to our understanding of inherited monogenic retinal diseases and age-related macular degeneration. Arch Ophthalmol 2007; 125: 160-164.
2. Ashtari M, Cyckowski LL, Monroe JF, Marshall KA, Chung DC, Auricchio A, Simonelli F, Leroy BP, Maguire AM, Shindler KS, Bennett J: The human visual cortex responds to gene therapy-mediated recovery of retinal function. J Clin Invest 2011; 121: 2160-2168.
3. Bennett J: Gene therapy for Leber congenital amaurosis. Novartis Found Symp 2004; 255: 195-202; discussion 202-197.
4. Jacobson SG, Aleman TS, Cideciyan AV, Sumaroka A, Schwartz SB, Windsor EA, Traboulsi EI, Heon E, Pittler SJ, Milam AH, Maguire AM, Palczewski K, Stone EM, Bennett J: Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci U S A 2005; 102: 6177-6182. (Pubitemid 40594274)
5. Koenekoop RK: Why some photoreceptors die, while others remain dormant: Lessons from RPE65 and LRAT associated retinal dystrophies. Ophthalmic Genet 2011; 32: 126-128.
6. Szobota S, Gorostiza P, Del Bene F, Wyart C, Fortin DL, Kolstad KD, Tulyathan O, Volgraf M, Numano R, Aaron HL, Scott EK, Kramer RH, Flannery J, Baier H, Trauner D, Isacoff EY: Remote control of neuronal activity with a light-gated glutamate receptor. Neuron 2007; 54: 535-545. (Pubitemid 46756151)
7. Nagel G, Szellas T, Huhn W, Kateriya S, Adeishvili N, Berthold P, Ollig D, Hegemann P, Bamberg E: Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci USA 2003; 100: 13940-13945. (Pubitemid 37499170)
8. Talcott KE, Ratnam K, Sundquist SM, Lucero AS, Lujan BJ, Tao W, Porco TC, Roorda A, Duncan JL: Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci 2011; 52: 2219-2226.
9. Stieglitz T: Development of a micromachined epiretinal vision prosthesis. J Neural Eng 2009; 6: 065005.
10. Zrenner E, Bartz-Schmidt KU, Benav H, Besch D, Bruckmann A, Gabel VP, Gekeler F, Greppmaier U, Harscher A, Kibbel S, Koch J, Kusnyerik A, Peters T, Stingl K, Sachs H, Stett A, Szurman P, Wilhelm B, Wilke R: Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci 2011; 278: 1489-1497.
11. Spandau UH, Rohrschneider K: Prevalence and geographical distribution of Usher syndrome in Germany. Graefes Arch Clin Exp Ophthalmol 2002; 240: 495-498. (Pubitemid 36097072)
12. Peterlin B, Canki-Klain N, Morela V, Stirn B, Rainer S, Cerar V: Prevalence of retinitis pigmentosa in Slovenia. Clin Genet 1992; 42: 122-123.
13. Rosenberg T, Haim M, Hauch AM, Parving A: The prevalence of Usher syndrome and other retinal dystrophy-hearing impairment associations. Clin Genet 1997; 51: 314-321. (Pubitemid 27248263)
14. Tous HM, Izquierdo NJ: Retinitis pigmentosa in Puerto Rico. P R Health Sci J 2006; 25: 315-318.
15. Krumpatszky HG: Blindness incidence in Germany: a population-based study from Württemberg-Hohenzollern. Ophthalmologica 1999: 176-182.
16. Ayuso C, Garcia-Sandoval B, Najera C, Valverde D, Carballo M, Antinolo G: Retinitis pigmentosa in Spain: the Spanish Multicentric and Multidisciplinary Group for Research into Retinitis Pigmentosa. Clin Genet 1995; 48: 120-122.
17. van den Born LI, Bergen AA, Bleeker-Wagemakers EM: A retrospective study of registered retinitis pigmentosa patients in the Netherlands. Ophthalmic Paediatr Genet 1992; 13: 227-236. (Pubitemid 23022192)
18. Heckenvlively Jr YS, Friedman LH, Oversier JJ: Clinical findings and common symptoms in retinitis pigmentosa. Am J Ophthalmol 1988: 504-511.
19. Tröger E, Prokofyeva E, Wilke R, Zrenner E: Reusability in patient registries-implamention of genericextensible web-based patient registry system; in Azevedo L LA (ed): Second International Conference on Health Informatics, HEALTHINF 2009. Porto, INSTICC, 2009, pp 438-441.
20. Tröger E, Wilke R, Prokofyeva E, Zrenner E: Ophthabase: a generic extensible patient registry system. Acta Ophthalmologica 2008; 86(suppl s243):0.
21. OMIM (an online catalog of human genes and genetic disorders). www.omim.org (accessed June 2011).
22. Szlyk JP, Fishman GA, Alexander KR, Revelins BI, Derlacki DJ, Anderson RJ: Relationship between difficulty in performing daily activities and clinical measures of visual function in patients with retinitis pigmentosa. Arch Ophthalmol 1997; 115: 53-59. (Pubitemid 27034931)
23. Hartong DT, Berson EL, Dryja TP: Retinitis pigmentosa. Lancet 2006; 368: 1795-1809. (Pubitemid 44739028)
24. Haim M: Prevalence of retinitis pigmentosa and allied disorders in Denmark. III. Hereditary pattern. Acta Ophthalmol (Copenh) 1992; 70: 615-624.
25. Haim M: Epidemiology of retinitis pigmentosa in Denmark. Acta Ophthalmol Scand suppl 2002; 233: 1-34.
26. Hamel CP: Cone rod dystrophies. Orphanet J Rare Dis 2007; 2: 7.
27. Ferreira PA: Insights into X-linked retinitis pigmentosa type 3, allied diseases and underlying pathomechanisms. Hum Mol Genet 2005; 14(spec No. 2):R259-R267. (Pubitemid 41631894)
28. Kaplan J, Bonneau D, Frezal J, Munnich A, Dufier JL: Clinical and genetic heterogeneity in retinitis pigmentosa. Hum Genet 1990; 85: 635-642. (Pubitemid 20364318)
29. Prokisch H, Hartig M, Hellinger R, Meitinger T, Rosenberg T: A population-based epidemiological and genetic study of Xlinked retinitis pigmentosa. Invest Ophthalmol Vis Sci 2007; 48: 4012-4018. (Pubitemid 351261023)
30. Akeo K, Saga M, Hiida Y, Oguchi Y, Okisaka S: Progression of visual field loss in patients with retinitis pigmentosa of sporadic and autosomal recessive types. Ophthalmic Res 1998; 30: 11-22. (Pubitemid 28043933)
31. Massof RW, Finkelstein D: A two-stage hypothesis for the natural course of retinitis pigmentosa; in Zrenner E, Krastel H, Goebel HH (eds): Research in Retinitis Pigmentosa. Oxford, Pergamon Press, 1987, vol 62, pp 29-58.
32. Audo I, Friedrich A, Mohand-Said S, Lancelot ME, Antonio A, Moskova-Doumanova V, Poch O, Bhattacharya S, Sahel JA, Zeitz C: An unusual retinal phenotype associated with a novel mutation in RHO. Arch Ophthalmol 2010; 128: 1036-1045.
33. Vaclavik V, Gaillard MC, Tiab L, Schorderet DF, Munier FL: Variable phenotypic expressivity in a Swiss family with autosomal dominant retinitis pigmentosa due to a T494m mutation in the PRPF3 gene. Mol Vis 2010; 16: 467-475.
34. Bessant DA, Holder GE, Fitzke FW, Payne AM, Bhattacharya SS, Bird AC: Phenotype of retinitis pigmentosa associated with the Ser-50Thr mutation in the NRL gene. Arch Ophthalmol 2003; 121: 793-802. (Pubitemid 36676215)